Spot the differences: Proteomics in cancer research

Lancet Oncology

Volumn 2, Issue 5, 2001, Pages 270-277

  Lawrie, Laura C ^a   Fothergill, John E ^a   Murray, Graeme I ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOME; TUMOR PROTEIN;

CELL CULTURE; HUMAN; METHODOLOGY; NEOPLASM; RESEARCH; REVIEW;

HUMANS; NEOPLASM PROTEINS; NEOPLASMS; PROTEOME; RESEARCH; TUMOR CELLS, CULTURED;

EID: 0035352362     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(00)00321-1     Document Type: Review

References (41)

1. Service R.F. News focus: can Celera do it again? Science. 287:2000;2136-2138.
2. Chambers G., Lawrie L., Cash P., et al. Proteomics: a new approach to the study of disease. J Pathol. 192:2000;280-288.
3. Langen H., Röder D. Separation of proteins from human embryonic kidney cells on narrow-range IPG strips. Life Science News 2000; 4: Amersham Pharmacia Biotech.
4. Tong W., Link A., Eng J.K., et al. Identification of proteins in complexes by solid-phase microextraction / multistep elution / capillary electrophoresis / tandem mass spectrometry. Anal Chem. 71:1999;2270-2278.
5. Patterson S.D. Proteomics: the industrialization of protein chemistry. Curr Opin Biotechnol. 11:2000;413-418.
6. Gygi S.P., Rist B., Gerber S.A., et al. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol. 17:1999;994-999.
7. Aebersold R., Rist B., Gygi S.P. Quantitative proteome analysis: methods and applications. Ann NY Acad Sci. 919:2000;33-47.
8. Chalmers M.J., Gaskell S.J. Advances in mass spectrometry for proteome analysis. Curr Opin Biotechnol. 11:2000;384-390.
9. Henzel W.J., Billeci T.M., Stults J.T., et al. Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases. Proc Natl Acad Sci USA. 90:1993;5011-5015.
10. Mann M., Hojrup P., Roepstorff P. Use of mass spectrometric molecular weight information to identify proteins in sequence databases. Biol Mass Spectrom. 22:1993;338-345.
11. Pappin D.J.C., Hojrup P., Bleasby A.J. Rapid identification of proteins by peptide-mass fingerprinting. Curr Biol. 3:1993;327-332.
12. Yates J.R. III, Speicher S., Griffin P.R., et al. Peptide mass maps: a highly informative approach to protein identification. Anal Biochem. 214:1993;397-408.
13. Shevchenko A., Wilm M., Vorm O., et al. Mass spectrometric sequencing of proteins from silver stained polyacrylamide gels. Anal Chem. 68:1996;850-858.
14. Fenyo D. Identifying the proteome: software tools. Curr Opin Biotechnol. 11:2000;391-395.
15. Celis J.E., Ostergaard M., Jensen N.A., et al. Human and mouse proteomic databases: novel resources in the protein universe. FEBS Lett. 430:1998;64-72.
16. http://biobase.dk/cgi-bin/celis.
17. Dunn M.J. Studying heart disease using the proteomic approach. Drug Dev Therapeutics. 5:2000;76-84.
18. Celis J.E., Rasmussen H.H., Vorum H., et al. Bladder squamous cell carcinomas express psoriasin and externalize it to the urine. J Urol. 155:1996;2105-2112.
19. Celis J.E., Celis P., Ostergaard M., et al. Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: A novel strategy for identifying metaplastic lesions. Cancer Res. 59:1999;3003-3009.
20. Prasannan L., Misek D.E., Hinderer R., et al. Identification of beta-tubulin isoforms as tumour antigens in neuroblastoma. Clin Cancer Res. 6:2000;3949-3956.
21. Soldes O.S., Kuick R.D., Thompson I.A., et al. Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas. Br J Cancer. 79:1999;595-603.
22. Stulík J., Koupilová K., Österreicher J., et al. Protein abundance alterations in matched sets of macroscopically normal colon mucosa and colorectal carcinoma. Electrophoresis. 20:1999;3638-3646.
23. Kutchera W., Jones D.A., Matsunami N., et al. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: Evidence for a transcriptional effect. Proc Natl Acad Sci USA. 93:1996;4816-4820.
24. Jungblut P.R., Zimny-Arndt U., Zeindl-Eberhart E., et al. Proteomics in human disease: cancer, heart and infectious diseases. Electrophoresis. 20:1999;2100-2110.
25. Ornstein D.K., Gillespie J.W., Paweletz C.P., et al. Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines. Electrophoresis. 21:2000;2235-2242.
26. Celis A., Rasmussen H.H., Celis P., et al. Short-term culturing of low-grade superficial bladder transitional cell carcinomas leads to changes in the expression levels of several proteins involved in key cellular activities. Electrophoresis. 20:1999;355-361.
27. Vercoutter-Edouart A.S., Czeszak X., Crepin M., et al. Proteomic detection of changes in protein synthesis induced by fibroblast growth factor-2 in MCF-7 human breast cancer cells. Exp Cell Res. 262:2001;59-68.
28. Page M.J., Amess B., Townsend R.R., et al. Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties. Proc Natl Acad Sci USA. 96:1999;12589-12594.
29. Stingl J., Eaves C.J., Kuusk U., et al. Phenotypic and functional characterization in vitro of a multipotent epithelial cell present in the normal adult human breast. Differentiation. 63:1998;201-213.
30. Curran S., McKay J.A., McLeod H.L., et al. Laser capture microscopy. Mol Pathol. 53:2000;64-68.
31. Emmert-Buck M.R., Bonner R.F., Smith P.D., et al. Laser capture microdissection. Science. 274:1996;998-1001.
32. Banks R.E., Dunn M.J., Forbes M.A., et al. The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis-preliminary findings. Electrophoresis. 20:1999;689-700.
33. Ornstein D.K., Englert C., Gillespie J.W., et al. Characterization of intracellular prostate-specific antigen from laser capture microdissected benign and malignant prostatic epithelium. Clin Cancer Res. 6:2000;353-356.
34. Emmert-Buck M.R., Gillespie J.W., Paweletz C.P., et al. An approach to proteomic analysis of human tumors. Mol Carcinogenesis. 27:2000;158-165.
35. von Eggeling F., Davies H., Lomas L., et al. Tissue-specific microdissection coupled with ProteinChip array technologies: applications in cancer research. Biotechniques. 29:2000;1066-1070.
36. McLeod H.L., Murray G.I. Tumour markers or prognosis in colorectal cancer. Br J Cancer. 79:1999;191-203.
37. Alizadeh A.A., Elsen M.B., Davis E.R., et al. Distinct cell types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 403:2000;503-511.
38. Gygi S.P., Corthals G.L., Zhang Y., et al. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc Natl Acad Sci USA. 97:2000;9390-9395.
39. Link J., Eng J., Schieltz D.M., et al. Direct analysis of protein complexes using mass spectrometry. Nat Biotechnol. 17:1999;676-682.
40. Ashman K., Houthaeve T., Clayton J., et al. The application of robotics and mass spectrometry to the characterisation of the Drosophila melanogaster indirect flight muscle proteome. Letters in Peptide Science. 4:1997;57-65.
41. Patton W.F. Making blind robots see: the synergy between fluorescent dyes and imaging devices in automated proteomics. Biotechniques. 28:2000;944-957.